| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A059QBD7 | Cytochrome c oxidase subunit 1; EC 1.9.3.1; | COX1; | NULL | 513 | human |
| A0A024QYW5 | LIM domain only 6, isoform CRA_a; | LMO6; | NULL | 615 | human |
| A0A059QFE2 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| A0A059QL46 | NADH-ubiquinone oxidoreductase chain 3; EC 1.6.5.3; | ND3; | NULL | 115 | human |
| F2X5Y8 | MHC class I antigen; Fragment; | HLA-A; | NULL | 181 | human |
| A0A059RXD5 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| F2Z395 | Coiled-coil domain-containing protein 17; | CCDC17; | NULL | 564 | human |
| A0A059RNI5 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| H3BTF2 | Cadherin-13; | CDH13; | NULL | 37 | human |
| E9PJ55 | T-complex protein 11-like protein 1; | TCP11L1; | NULL | 595 | human |
| K9N1J3 | Interleukin 15 receptor alpha isoform IC5; | il15ra; | NULL | 308 | human |
| M0QYB1 | SH3KBP1-binding protein 1; Fragment; | SHKBP1; | NULL | 250 | human |
| A0A067ZUL6 | Nuclear pore complex-interacting protein; Fragment; | NPIP; | NULL | 234 | human |
| A0A068B433 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| J3KQ40 | TBC1 domain family member 8; | TBC1D8; | XP_005263920.1; | 1155 | human |
| D6RB73 | Solute carrier family 35 member B1; Fragment; | SLC35B1; | NULL | 254 | human |
| A0A075X8G3 | NADH dehydrogenase subunit 2; Fragment; | ND2; | NULL | 92 | human |
| M0QZI8 | Kallikrein-11; Fragment; | KLK11; | NULL | 170 | human |
| E5KYG1 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NULL | 174 | human |
| M0QXE9 | ATP-dependent Clp protease proteolytic subunit, mitochondrial; | CLPP; | NULL | 56 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |